期刊文献+

心血管事件高危患者餐后C反应蛋白质量浓度变化及辛伐他汀干预结果分析 被引量:4

Influence of simvastatin on postprandial C-reactive protein concentrations in patients at high risk of cardiovascular event
原文传递
导出
摘要 目的研究心血管事件高危患者高脂餐后血浆C反应蛋白(CRP)质量浓度的变化,探讨极短期辛伐他汀对血浆CRP质量浓度的影响。方法对肇庆市端州区人民医院于2003-10-2004-0670例冠心痛及其高危症患者随机分为辛伐他汀组(36例)和常规治疗组(34例),分别在常规治疗的基础上加服辛伐他汀(20mg/d)和安慰剂。治疗前和1周后接受高脂餐负荷试验,检测空腹和餐后4h血浆CRP质量浓度和血脂水平。结果两组患者的餐后血浆甘油三酯和CRP质量浓度较空腹水平明显升高(P<0.05)。1周后常规治疗组的空腹和餐后血浆CRP质量浓度和血脂水平无显著变化;辛伐他汀组的餐后血浆甘油三酯和CRP质量浓度较治疗前显著降低,但血浆CRP质量浓度降低与血脂的变化无显著相关。结论极短期辛伐他汀治疗有效降低心血管事件高危患者餐后升高的血浆CRP质量浓度。 Objective To study the changes of postprandial plasma C-reactive protein(CRP)concentrations after a high-fat meal (800 calorie;50g fat) in patients at high risk of cardiovascular event,and explore the influence of simvastatin on CRP concentration in very short time. Methods 70 patients at high risk of cardiovascular disease were randomly divided into two groups to accept either simvastatin (20mg/d) (SIM group, n=36)or placebo (ROU group, n=34) at the base of routine therapy. All patients received an oral high-fat meal at baseline and one week later. The concentrations of plasma triglyceride(TG), total cholesterol, LDL-cholesterol, HDL-cholesterol and CRP in fasting state and at 4 hours postprandially were measured. Results The postprandial plasma TG and CRP concentrations increased significantly ( P <0.05) in all patients. After one week, the fasting or postprandial plasma lipids levels and CRP concentration did not change significantly in ROU group comparing to the baseline, while the postprandial plasma TG and CRP concentrations significantly decreased in SIM group. The reduction of plasma CRP concentration was not significantly related to the changes of plasma lipids levels. Conclusion Simvastatin can effectively reduce postprandial plasma CRP concentrations in patients at high risk of cardiovascular event in very short time.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2005年第7期598-600,共3页 Chinese Journal of Practical Internal Medicine
关键词 冠状动脉疾病 危险因素 C反应蛋白质 降血脂药 Coronary disease Risk factors C-reactive protein Antilipemic agents
  • 相关文献

参考文献6

  • 1Zahedi RG,Summers LK,Lumb P,et al.The response of serum sialic acid and other acute phase reactants to an oral fat load in healthy humans.Eur J Intern Med,2001,12(4):510-514
  • 2Liu L,Zhao SP,Gao M,et al.Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal.Clin Cardiol,2002,25(3):219-224
  • 3彭峰,林金秀,曾开淇,康晴,吴可贵.肥胖和高血压患者餐后甘油三酯代谢异常与胰岛素抵抗的关系[J].中华心血管病杂志,2003,31(7):509-513. 被引量:19
  • 4Gronholdt ML,Sillesen H,Wiebe BM,et al.Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume.Eur J Vasc Endovasc Surg,2001,21(2):227-234
  • 5孙瑜,柏愚,赵仙先.他汀类药物的调脂外作用[J].心血管病学进展,2003,24(1):4-7. 被引量:25
  • 6Ridker PM,Rifai N,Pfeffer MA,et al.Long-term effects of provastatin on plasma concentration of C-reactive protein:cholsterol and recurrent events study.Circulation,1998,98(9):839-844

二级参考文献46

  • 1陈达光,林金秀,曾开淇,郑舒亮,黄端,李宝彬.肥胖和高血压病患者胰岛素敏感性的变化[J].中华医学杂志,1996,76(7):519-523. 被引量:44
  • 2[1]Wassmann S, Laufa U, et al. Inhibition of geranylgeranylation reduces angiotensin Ⅱ-mediated free radical production in vascular smooth muscle cells: involvment of angiotensin AT1 receptor expression and Racl GTPase [J]. Mol Pharmacol,2001 ,59:646-654.
  • 3[2]Fukumoto Y, Libby P, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits [J]. Circulation,2001,103:993-999.
  • 4[3]Gotto FM. Lipid-lowering therapy for the primary prevention of coronary heart disease[J]. J Am Coll Cardiol, 1999,33:2078-2082.
  • 5[4]Sindermann J, Weigel K, Muller JG, et al. Induction of p53 and interleukin-8 by HMG-CoA reductase inhibitors in human coronary smooth muscle cells ( Abstract) [J]. Eur Heart J,1997,18:371.
  • 6[5]Kaneider NC, Reinisch CM, et al. Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin [J]. Atherosclerceis,2001,158(1) :233-235.
  • 7[6]Knapp AC,Huang J,et al. Inhibition of HMC-CoA reductase sensitize human smooth muscle cells to Fas-ligand and oytokine-induced cell death[J]. Atherosclerosis ,2000,153:217-227.
  • 8[7]Alonso R, Mats P,et al. Sustained long-term improvement of arterial endothelial function in heteraozygous familial hypercholesterolemia patients treated with sitmvastatin [J]. Atherosclerosis ,2001,157:423-429.
  • 9[8]Allan ML, Rosario Scalia, David JL. Vascular effects of HMG CoA-reductase inhibitors(statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease [J]. Cardiovascular Research, 2001,49: 281-287.
  • 10[9]M ueck AO, Seeger H, et al. Further evidence for direct vascular actions of statins :effect on endothelial n itric oxide eynthase and adhesion moleculee[J]. Exp Clin Endocrinol Diabetes,2001,109:181-183.

共引文献42

同被引文献31

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部